Altimmune (ALT) Net Margin (2016 - 2025)
Historic Net Margin for Altimmune (ALT) over the last 17 years, with Q3 2025 value amounting to 380280.0%.
- Altimmune's Net Margin rose 766200000.0% to 380280.0% in Q3 2025 from the same period last year, while for Sep 2025 it was 420165.0%, marking a year-over-year decrease of 2210880800.0%. This contributed to the annual value of 475535.0% for FY2024, which is 4547727900.0% down from last year.
- Altimmune's Net Margin amounted to 380280.0% in Q3 2025, which was up 766200000.0% from 442920.0% recorded in Q2 2025.
- Altimmune's Net Margin's 5-year high stood at 728.99% during Q4 2021, with a 5-year trough of 1175650.0% in Q3 2022.
- Its 5-year average for Net Margin is 273064.08%, with a median of 251650.0% in 2022.
- As far as peak fluctuations go, Altimmune's Net Margin plummeted by 2000000000bps in 2022, and later skyrocketed by 2000000000bps in 2023.
- Altimmune's Net Margin (Quarter) stood at 728.99% in 2021, then crashed by -11328bps to 83307.69% in 2022, then decreased by -3bps to 85516.22% in 2023, then crashed by -445bps to 465960.0% in 2024, then increased by 18bps to 380280.0% in 2025.
- Its Net Margin was 380280.0% in Q3 2025, compared to 442920.0% in Q2 2025 and 391500.0% in Q1 2025.